Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy [NA]
Clinical trial evaluating FibroScan in patients with cirrhosis, hepatitis B, or hepatitis C undergoing liver biopsy has completed and posted…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNA
This completed clinical trial assesses how varying concentrations of Sofosbuvir and Daclatasvir influence Hepatitis C RNA levels.
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C [Phase 1, Phase 2]
A Phase I/II trial evaluating an autologous dendritic cell vaccine transduced with an adenoviral NS3 vector for chronic hepatitis C was term…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection [Phase 3]
Phase 3 trial update of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with low-dose ribavirin in genotype 1a chronic hepatitis C, complete…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 [Phase 4]
Phase 4 trial update for an individualized treatment approach in chronic hepatitis C patients (Genotype 2/3) completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067) [Phase 3]
A Phase 3 trial of the Grazoprevir/elbasvir combination in treatment-naïve hepatitis C patients has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection [Phase 2]
Phase 2 clinical trial update of faldaprevir, TD-6450 and other antivirals in genotype 1b Hepatitis C; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection [Phase 3]
Phase 3 trial evaluating ABT-493/ABT-530 (glecaprevir/pibrentasvir) in renally impaired adults with chronic hepatitis C virus infection geno…
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV) [Phase 2]
Phase 2 study evaluating safety and antiviral effect of ABT-493 and ABT-530 in adults with genotype 1 hepatitis C, completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: A Retrospective, Observational Study on the Effectiveness of Daclatasvir-Containing Regimens in Patients in KSA, UAE and Qatar
A completed retrospective observational study evaluated the effectiveness of daclatasvir-containing regimens for Hepatitis C in patients in …
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4
A clinical trial update investigating the sustained virologic response of daclatasvir in Egyptian patients with hepatitis C virus genotype 4…
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C
A completed study assessing predictors of pegylated interferon effectiveness in chronic hepatitis C participants, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: A Study of Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response [Phase 4]
Phase 4 study updating extended therapy with peginterferon alfa-2a plus ribavirin in chronic hepatitis C slow responders; study completed wi…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating co-administration of ABT-493 and ABT-530 with and without RBV for chronic HCV genotypes 2-6; re…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Effect Of DAAs For Treatment Of HCV On Normal Kidney [Phase 4]
Phase 4 clinical trial update on the effect of direct-acting antivirals (DAAs) for hepatitis C treatment on normal kidney function.
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis [Phase 3]
Phase 3 trial evaluating ABT-493/ABT-530 for efficacy and safety in adults with chronic hepatitis C virus infection (genotypes 1, 2, 4, 5, o…
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6 [Phase 4]
Phase 4 trial comparing fixed-dose combination sofosbuvir/ledipasvir for 8 vs 12 weeks in chronic hepatitis C genotype 6; results posted aft…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection [Phase 3]
Phase 3 trial evaluating ABT-493/ABT-530 for chronic hepatitis C virus genotype 2 infection has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection [Phase 3]
Phase 3 trial comparing ABT-493/ABT-530 to Sofosbuvir with Daclatasvir in adults with HCV genotype 3 has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy [Phase 2, Phase 3]
Phase 2/3 trial evaluating ABT-493 and ABT-530 with and without ribavirin in adults with hepatitis C who failed prior DAA therapy; completed…
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection [Phase 2]
Phase 2 trial evaluating safety and efficacy of Voxilaprevir plus Sofosbuvir/Velpatasvir fixed-dose combination in adults with chronic non-g…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4) [Phase 3]
Phase 3 trial ENDURANCE-4 evaluated ABT-493/ABT-530 for chronic hepatitis C virus infection genotypes 4, 5, or 6; results completed with pos…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection [Phase 3]
Phase 3 trial update for ABT-493/ABT-530 evaluating efficacy and safety in genotype 1 hepatitis C infection; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of a fixed-dose regimen of Sofosbuvir/Velpatasvir/Voxilaprevir with or without Ribavirin …
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C [Phase 2]
Phase 2 trial investigating infliximab with pegylated interferon and ribavirin for hepatitis C has completed with results posted.